Formidable Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Formidable Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-85	Closed	-$4K	–	384
2016 Q1	$4K	Sell	85 -166	-66%	-$9.74K	﹤0.01%	426
2015 Q4	$16K	Sell	251 -50	-17%	-$3.09K	0.01%	329
2015 Q3	$16K	Buy	+301	New	+$19.5K	0.01%	345
2014 Q3	–	Sell	-467	Closed	-$24K	–	506
2014 Q2	$24K	Buy	+467	New	+$23.9K	0.01%	262
2014 Q1	–	Sell	-467	Closed	-$21K	–	491
2013 Q4	$21K	Buy	+467	New	+$18.4K	0.01%	264

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Formidable Asset Management's TEVA Position: Q2 2016 in Review

Formidable Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 85 shares — an estimated $4K sold.

Formidable Asset Management first reported a position in TEVA in Q4 2013 and held it in 5 quarters. The position peaked at $24K in Q2 2014. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

Formidable Asset Management reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Formidable Asset Management sold 85 Teva Pharmaceuticals shares in Q2 2016, an estimated $4K.
Formidable Asset Management first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 5 quarters.
Formidable Asset Management's Teva Pharmaceuticals position peaked at $24K in Q2 2014.
812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Formidable Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.